TuHURA Biosciences (HURA) Enterprise Value (2010 - 2026)
TuHURA Biosciences (HURA) posted quarterly Enterprise Value of -$6.3 million for Q1 2026, down 1.29% year-over-year from -$6.4 million in Q1 2025, and down 74.04% quarter-over-quarter from -$3.6 million in Q4 2025.
TuHURA Biosciences (HURA) Enterprise Value (2010 - 2026) Analysis & Trends
TuHURA Biosciences' Enterprise Value history runs 17 years deep, the most recent figure standing at -$6.3 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 1.29% year-over-year to -$6.3 million; the TTM figure through Mar 2026 stood at -$6.3 million (down 1.29% YoY), while the FY2025 annual figure was -$3.6 million, up 71.4% from the prior year.
- Enterprise Value for Q1 2026 stood at -$6.3 million, down from -$3.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$216000.0 in Q3 2023, with the low at -$12.7 million in Q4 2024.
- The 5-year median for Enterprise Value is -$4.9 million (2024), against an average of -$5.6 million.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 96.95% in 2023, then tumbled 1298.15% in 2024.
- TuHURA Biosciences' Enterprise Value stood at -$4.9 million in 2022, then climbed by 24.8% to -$3.7 million in 2023, then slumped by 245.35% to -$12.7 million in 2024, then jumped by 71.4% to -$3.6 million in 2025, then plunged by 74.04% to -$6.3 million in 2026.
- Business Quant data shows HURA's Enterprise Value at -$6.3 million in Q1 2026, -$3.6 million in Q4 2025, and -$2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | -1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.30 Mn |
| Dec 31, 2025 | -3.62 Mn |
| Sep 30, 2025 | -2.70 Mn |
| Jun 30, 2025 | -8.50 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Dec 31, 2024 | -12.66 Mn |
| Sep 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -4.91 Mn |
| Mar 31, 2024 | -6.35 Mn |
| Dec 31, 2023 | -3.67 Mn |
| Sep 30, 2023 | -216,000.00 |
| Jun 30, 2023 | -1.54 Mn |
| Mar 31, 2023 | -3.05 Mn |
| Dec 31, 2022 | -4.87 Mn |
| Sep 30, 2022 | -7.09 Mn |
| Jun 30, 2022 | -11.78 Mn |
| Mar 31, 2022 | -8.84 Mn |
| Dec 31, 2021 | -14.06 Mn |
| Sep 30, 2021 | -19.34 Mn |
| Jun 30, 2021 | -10.54 Mn |